CIS School in Systemic Autoimmune Diseases

描述（由申请人提供）：该补助金要求支持研究员参加2008年临床免疫学会（CIS）系统性自身免疫疾病学校的差旅费和费用。这项补助金是要求帮助支付旅费为美国同胞旅行和费用参加学校。将向制药和生物技术公司寻求额外资金。 这所学校将于2008年4月2日至6日在马萨诸塞州波士顿举行为期四天的密集住宿课程。该计划将通过CIS和美国流变学学院的学术项目主任和成员以及其他对临床免疫学感兴趣的主要学会进行宣传。将强调广告宣传，以吸引代表少数群体的申请人。 学校的主题将是系统性自身免疫疾病，面向在培训持有医学博士和/或博士学位的研究员，在他们的奖学金培训的最后几年。学校的主要目标是教育系统性自身免疫性疾病的诊断，发病机制和治疗，如SLE，硬皮病，关节炎，血管炎以及基因治疗。这些演讲将包括主题概述，最先进的治疗方法，实验室方法，发病机制和未来的生物制剂。重点将放在正在开发的新疗法和未来的可能性。将分配足够的时间让研究员介绍有趣的案例或他们的工作。 到学校结束时，参与者应该能够更好地诊断和治疗系统性自身免疫性疾病;提高对与系统性自身免疫性疾病相关的临床免疫学过程及其在科学发现和临床应用中的重要性的认识;并雄心勃勃地追求学术事业，以进一步了解，诊断和治疗人类系统性自身免疫性疾病。最后，学校应该鼓励未来的合作，在不同的医疗中心和国家的年轻研究人员之间，以及年轻的研究人员和有经验的医生/科学家在该领域。 学校将是住宅性质，并在非正式的环境中举行，将吸引来自北美，欧洲和亚洲的申请人。14名教师和25名研究员将被选中参加。

DESCRIPTION (provided by applicant): This grant requests support for travel and expenses of fellows to attend the 2008 Clinical Immunology Society (CIS) School in Systemic Autoimmune Diseases. This grant is requested to help defray travel costs for the U.S. fellow travel and expenses to attend the School. Additional funding will be solicited from pharmaceutical and biotechnology companies. This School will be an intensive four-day residential course to be held on April 2-6, 2008 in Boston, Massacheusetts. The program will be advertised through academic program directors and members of the CIS and the American College of Rheumatology as well as through other major societies with interests in clinical immunology. Advertising emphasis will be given to attract applicants representing minorities. The topic of the School will be Systemic Autoimmune Diseases, geared toward fellows in training holding either an MD and/or a PhD, within their last years of fellowship training. The primary goal of the School is education on the diagnosis, pathogenesis, and treatment of systemic autoimmune diseases such as SLE, Scleroderma, Arthritis, Vasculitis as well as gene therapy. These presentations will include topic overviews, state of the art established treatments, laboratory approaches, pathogenesis and future biologics. Emphasis will be given to new treatments that are under development and future possibilities. Sufficient time will be allocated for fellows to present either interesting cases or their work. By the end of the School, participants should be able to better diagnose and treat systemic autoimmune diseases; have an enhanced awareness of clinical immunology processes as they relate to systemic autoimmune diseases and its importance in scientific discoveries and clinical application; and become ambitious in pursuing academic careers to further our understanding, diagnosis and treatment of human systemic autoimmune diseases. Lastly, the School should stimulate future collaborations between young investigators in different medical centers and countries, and between young investigators and experienced physician/scientists in the field. The School will be residential in character and held in an informal setting and will attract applicants from the North America, Europe and Asia. Fourteen faculty and twenty-five fellows will be selected to attend.